Flagship Harbor Advisors
GCVRZ

Flagship Harbor Advisors’s Sanofi Contingent Value Rights GCVRZ Stock Holding History

Flagship Harbor Advisors’s Portfolio GCVRZ Stock Details GCVRZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-2,477
Closed -$2K – 2062
2019
Q4 		$2K Sell
2,477
-12,414
-83% -$9.5K ﹤0.01% 1773
2019
Q3 		$8K Hold
14,891
– – ﹤0.01% 1369
2019
Q2 		$7K Hold
14,891
– – ﹤0.01% 1427
2019
Q1 		$6K Hold
14,891
– – ﹤0.01% 1473
2018
Q4 		$7K Hold
14,891
– – ﹤0.01% 1377
2018
Q3 		$8K Hold
14,891
– – ﹤0.01% 1561
2018
Q2 		$7K Hold
14,891
– – ﹤0.01% 1560
2018
Q1 		$6K Hold
14,891
– – ﹤0.01% 363
2017
Q4 		$6K Hold
14,891
– – ﹤0.01% 369
2017
Q3 		$5K Hold
14,891
– – ﹤0.01% 345
2017
Q2 		$6K Sell
14,891
-13,000
-47% -$5.31K ﹤0.01% 343
2017
Q1 		$12K Hold
27,891
– – ﹤0.01% 324
2016
Q4 		$13K Buy
+27,891
New +$9.44K 0.01% 288

Flagship Harbor Advisors's GCVRZ Position: Q1 2020 in Review

Flagship Harbor Advisors sold out of Sanofi Contingent Value Rights (GCVRZ) in Q1 2020, closing a stake of 2,477 shares — an estimated $2K sold.

Flagship Harbor Advisors first reported a position in GCVRZ in Q4 2016 and held it in 13 quarters. The position peaked at $13K in Q4 2016. 2 funds tracked by Wall St. Rank hold GCVRZ as of Q1 2020.

  • Flagship Harbor Advisors reported no remaining Sanofi Contingent Value Rights position as of Q1 2020 after selling out during the quarter.
  • Flagship Harbor Advisors sold 2,477 Sanofi Contingent Value Rights shares in Q1 2020, an estimated $2K.
  • Flagship Harbor Advisors first reported a position in Sanofi Contingent Value Rights in Q4 2016 and held it in 13 quarters.
  • Flagship Harbor Advisors's Sanofi Contingent Value Rights position peaked at $13K in Q4 2016.
  • 2 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q1 2020.

Based on Flagship Harbor Advisors's 13F filing for Q1 2020, filed 12 May 2020.